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unlikely that the modest IABP–induced pulse pressure of
only 24 ± 8 mm Hg would generate a dp/dt of 645 ± 64 mm
Hg/s, particularly at the level of small cerebral arteries, and
thus be enough to produce sufficient stretch to induce signif-
icant production of L-arginine in the small cerebral arteries. If
the pulse pressure was not sufficient, then significant cerebral
vasodilation would not be obtained to affect the SjvO2, and
hence the IABP-induced pulsatility would be unable to ame-
liorate the impaired SjvO2. A similar study using a pulsatile
system capable of producing a pulse pressure of 50 to 60 mm
Hg6 to mimic that produced by the natural heart would be
needed to be able to definitely exclude or include the role
played by pulsatility. The study only demonstrates that the
modest IABP-induced pulsatility was not effective but by no
means excludes the role pulsatility may have.
3. It is widely known that during CPB the levels of circu-
lating endogenous catecholamines including norepinephrine
are increased. During systemic infusion of norepinephrine,
increased electrical brain activity (consisting of increased
low-voltage high-frequency waves and decreased high-volt-
age slow-frequency waves) suggestive of promotion of exci-
tatory (N-methyl-D-aspartate?) receptor activation has been
noted in nonischemic rabbits (unpublished observations of
electroencephalograms concurrent to brain microdialysis
studies), which may lead to Na+ and Ca++ influx. To maintain
the normal Na+ and Ca++ transmembrane gradient, the
demand for mechanisms to extrude them, which are highly
oxygen consuming, will be increased. Therefore during late
CPB the decreased SjvO2 might be a manifestation of that
increased oxygen extraction not counteracted by the anes-
thetics, pressures, or pulsatility used by the authors. The exact
effect of increased circulating catecholamines during CPB on
the cerebral vasculature is not known, but if it was equivalent
to increased sympathetic activity, then vasoconstriction of
small cerebral vessels would result with consequent
decreased flow.7 If both effects are operating, the develop-
ment of decreased SjvO2 over the first 20 minutes of perfusion
and the return to normal after CPB, also in 20 or 30 minutes,
are easily explainable.
Norepinephrine determination with and without blockade
in conjunction with metabolic studies across the brain in both
groups might shed some light.
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Reply to the Editor:
We appreciate the comments of Miyamoto and Miyamoto.
As we described previously, it is not clear which type of pul-
satile waveform has positive effects on cerebral circulation
and improves outcome of patients.1
The internal jugular venous oxygen saturation (SjvO2)
value expressed in Fig 1 was the value measured in a blood
sample drawn from a jugular venous catheter. At the same
time, we continuously measured the SjvO2 value and region-
al cerebral oxygenation using an analysis system (Explorer
system, Baxter Healthcare Corp, Irvine, Calif) and found that
there were no changes in the SjvO2 and regional cerebral oxy-
genation values throughout the study. In our previous study,2
we reported a close correlation between the oxygen satura-
tion value measured by the optical catheter and the oxygen
saturation value in sampled blood by the blood gas analyzer.
Therefore we do not think that the change in Sjvo2 would be
observed if the value had been measured more frequently
during cardiopulmonary bypass (CPB). It remains controver-
sial whether cerebral autoregulation is intact during CPB.3,4
Newman and associates3 reported that an increase in cerebral
blood flow was observed by an increase in mean arterial pres-
sure. In contrast, Sadahiro and the associates4 reported that
cerebral blood flow was constant when mean arterial pressure
was higher than 50 mm Hg. At present, there is no solid
agreement concerning the acceptable level of mean arterial
pressure during CPB.
As we described previously, however, our pulse pressure
was a physiologic pulse waveform. A higher pulse pressure
(>40 mm Hg) might have had a positive effect of high-pres-
sure intra-aortic balloon pumping (IABP) on cerebral circu-
lation.1
We did not measure the plasma catecholamine levels in the
two groups; therefore it was not known whether plasma lev-
els could have some effects on cerebral microcirculation in
our study. Cerebral microcirculation might be affected by
plasma catecholamine level, as they described. However,
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other factors, such as renin-angiotensin and thromboxane A2,
might have effects on cerebral microcirculation.5
Yuji Kadoi, MD
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Vasodilatation after cardiac surgery
To the Editor:
Argenziano and associates,1 in their article on management
of vasodilatory shock after cardiac surgery, provide an excel-
lent study of enormous clinical importance. Identification of
low ejection fraction and angiotensin-converting enzyme
(ACE) inhibitors as risk factors for vasodilatory shock after
cardiopulmonary bypass (CPB) confirms the initial analysis
of 2729 patients undergoing CPB in our center.
However, the study raises a number of important issues that
were not mentioned:
While discussing the mechanisms for arginine vasopressin
deficiency, which may be multifactorial, the authors failed to
mention that angiotensin II decreases arginine vasopressin
release from the neurohypophysis.2 This implies that the
newer selective angiotensin II inhibitors like losartan may
also cause vasodilatory shock.
The majority of patients undergoing routine CPB, regard-
less of left ventricular function, have no sequelae if the ACE
inhibitor is withheld on the morning of the operation. With-
holding the ACE inhibitor also may decrease the chance of
renal complications via the reduced efferent arterial tone
caused by ACE inhibitors, which reduces glomerular filtra-
tion rate during CPB.3 Obviously, withholding the ACE in-
hibitor is not appropriate in patients awaiting cardiac trans-
plantation or left ventricular assist device implantation, but
the ACE inhibitor could be changed to a short-acting one
from the long-acting one that most patients receive.
Amiodarone, which is a noncompetitive α-blocker and β-
blocker, is commonly co-prescribed with ACE inhibitors in
patients with end-stage cardiac failure before heart transplan-
tation.4 Amiodarone has been shown to act synergistically
with ACE inhibitors in causing vasodilatory shock via a two-
hit mechanism.5 Unfortunately no mention was made of this.
Finally, nicorandil, a new potassium channel opener used
in the treatment of angina, in our experience, has been asso-
ciated with decreased systemic vascular resistance and
increased need for vasoconstrictor treatment.6 This seems to
be especially common when patients have taken a 10-mg
dose within 12 hours of CPB.
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Posterior aortoventricular bleeding after aortic valve
replacement with the stentless Cryolife-O’Brien
valve
To the Editor
Mediratta, Sosnowski, and Galiñanes1 have pointed out the
possibility of posterior aortoventricular bleeding after supra-
annular aortic valve replacement with a stentless prosthesis.
Such complications are directly related to extensive decalci-
fication of the aortic anulus (along the left coronary part of
the anulus).
We have now implanted nearly 400 Cryolife-O’Brien
valves (Cryolife International, Atlanta, Ga) in our hospital,
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